Previous Close | 44.14 |
Open | 44.26 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 43.93 - 46.19 |
52 Week Range | 19.80 - 53.29 |
Volume | |
Avg. Volume | 478,860 |
Market Cap | 2.589B |
Beta (5Y Monthly) | 0.75 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -6.50 |
Earnings Date | Oct 31, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 54.71 |
CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, October 31, 2024, at 8:00 a.m. ET to report its third quarter 2024 financial results and business highlights. A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the comp
Investors need to pay close attention to Agios (AGIO) stock based on the movements in the options market lately.